[120 Pages Report] Bowel/fecal incontinence refers to a patient�s inability to control bowel movements, which results in involuntary loss of solid or liquid stool. It is caused due to diarrhea, constipation, weaker muscle tone (that controls the opening of the anus), and chronic medical conditions (such as diabetes, multiple sclerosis, and nerve damage). The clinical devices used to manage bowel activity are called bowel management systems

The global bowel management systems market is projected to reach USD 2.07 billion by 2023, at a CAGR of 3.5%. Some of the major factors driving the growth of this market are: expanding target patient population, rapidly growing geriatric population, availability of technologically advanced bowel management products, and favorable reimbursement scenario in developed countries.

�By product, colostomy bags segment to witness the highest growth during the forecast period"

The colostomy bags segment is expected to account for the largest share of the bowel management systems market.

�By patient type, Adult patients segment to grow at the highest rate during the forecast period.�

The adult patient segment is estimated to account for the larger share of the bowel management systems market. While fecal incontinence (FI) affects individuals of all ages, it is more common in middle-aged and older adults due to their greater prevalence of neurologic diseases and weaker muscle tone. Additionally, the prevalence of FI is reported to be twice among women as compared to men, owing to the risk of injuries to the anal sphincter during childbirth

�The home care segment will grow at a higher CAGR during the forecast period.�

Factors such as the significant usage and growing adoption of bowel management products in home care settings, need for device replacement on a regular basis, and rising incidence of chronic disorders are expected to support the growth of the home care segment during the forecast period

�The RoW is expected to grow at the highest rate during the forecast period.�

The Rest of the World (RoW) comprises countries in Latin America (including Brazil, Mexico, Peru, and Chile), the Middle East (including Egypt, Iran, Turkey, and Iraq), and Africa (including South Africa, Egypt, Ghana, and Nigeria). Rising market growth can be attributed to the growing target patient population, the ongoing expansion of healthcare infrastructure, and initiatives to enhance patient awareness.

Market Dynamics

Driver: Favorable reimbursement scenario in developed countries

The developed countries are reported to have favorable reimbursement scenarios for bowel management products, owing to which the demand for these products is expected to grow positively during the study period.

Restraint: Patient preference for non-invasive clinical management of FI

Currently, FI can be managed invasively (surgically) or non-invasively. Standard modes of surgical treatment include the injection of biomaterials into the anal canal, radiofrequency treatment of the anal canal, surgical repair of anal muscle injuries, sacral nerve stimulation, artificial bowel sphincter, muscle transposition to reinforce the anal sphincter, and the creation of a stoma. These often require long-term patient rehabilitation and maybe highly inconvenient and even severely painful.

As a result, the preference has grown for non-invasive approaches, such as the use of disposable products, medications, dietary and lifestyle changes, exercise, biofeedback, bowel training, transanal irrigation, antegrade colonic irrigation, and electrical stimulation. Additionally, these treatment alternatives are considered by surgeons as the first line of treatment as well. The significant adoption and patient preference for non-invasive treatment alternatives are expected to hamper the optimal growth of the bowel management systems market during the forecast period.

Challenge: Underreporting of FI

FI is among the most common pathophysiological medical conditions among the elderly population and women worldwide. Geriatric women are exposed to a greater risk of FI due to anal sphincter damage during pregnancy and childbirth. However, most patients suffering from FI are reluctant to report their clinical condition mainly out of embarrassment. Healthcare professionals also often fail to inquire about FI due to insufficient training regarding the latest options of FI treatment.

Thus, reluctance on the part of patients to report fecal incontinence is expected to be a key barrier for the optimal adoption of bowel management systems across respective geographies during the study period.

Scope of the Report

Report Metric Details Market size available for years 2016�2023 Base year considered 2017 Forecast period 2018�2023 Forecast units USD million Segments covered Product, Patient Type, End-User, and Region. Geographies covered North America, Europe, APAC, and the Rest of the World (RoW) Companies covered Coloplast (Denmark), Medtronic (Ireland), 3M (US), B. Braun (Germany), C.R. Bard (US), ConvaTec (UK), Consure Medical (India), Cogentix Medical (US), Aquaflush Medical Limited (UK), Axonics Modulation Technologies (US), ConvaTec (UK), Hollister (US), MBH-International A/S (Denmark), Mederi Therapeutics Inc. (US), Welland Medical Limited (UK), and Wellspect HealthCare (Sweden)

This report categorizes the global bowel management systems market into the following segments and sub-segments:

Irrigation Systems

Nerve Modulation Devices

Colostomy Bags

Other Products and Accessories*

*Note: Other products and accessories include radiofrequency devices, surgical implants, artificial anal sphincters, anal plugs, bowel management accessories (such as tubes, stool bags, pouches, and rectal catheters), and colostomy accessories.

Adult

Pediatric

Bowel Management Systems Market, by End User

Hospitals and Ambulatory Surgery Centers

Home Care

Bowel Management Systems Market, by Region

North America US Canada

Europe Germany France UK Italy Spain Rest of Europe (RoE)

Asia Pacific Japan China India Rest of Asia Pacific (RoAPAC)

Rest of the World (RoW) Latin America Middle East and Africa



Key Market Players

The key market players in the bowel management systems market are: Coloplast (Denmark), Medtronic (Ireland), Hollister (US), and ConvaTec (UK)

Coloplast develops and markets healthcare products and services and caters to hospitals, institutions, wholesalers, and retailers. The company operates through four segments, namely, Ostomy Care, Urology Care, Continence Care, and Wound & Skin Care. Coloplast offers bowel irrigation products through its Continence Care segment under the brand Peristeen. The company also offers ostomy care products under Brava, SenSura, SenSura Mio, and Assura brands. A wide product portfolio helps Coloplast to cater to the varied needs of its diverse customer segments. It also helps the company to garner a significant share in the bowel management products market.

Recent Developments

In 2018, Coloplast acquired IncoCare, a provider of continence products. This acquisition helped Coloplast expand its presence in Germany.

In 2018, Axonics received marketing approval for its Axonics Sacral Neuromodulation System in Australia

In 2018, Coloplast expanded its product portfolio by introducing a new product, SenSura Mio Concave, into its SenSura Mio product line.

In 2016, ConvaTec entered into an agreement with Vizient, Inc. According to this agreement, members of Vizient get access to ConvaTec�s stoma care, bowel management, and patient skincare products.

In 2016, A German court affirmed ConvaTec�s patent protection on Flexi-Seal Fecal Management System and ordered the competitor to cease from placing its product (infringing patent) in the market, as well as to recall its product already sent to market and to compensate ConvaTec.

Critical questions the report answers:

Where will all these developments take the bowel management systems market in the long term?

What are the upcoming trends for the bowel management systems market? Which segment in the bowel management market provides the most opportunity for growth?

Who are the leading vendors operating in the market? What are the opportunities for new market entrants in the bowel management market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst